Food Advisory Committee; Notice of Meeting; Amendment of Notice, 67438-67439 [2014-26823]
Download as PDF
67438
Federal Register / Vol. 79, No. 219 / Thursday, November 13, 2014 / Notices
to read ‘‘Current Status of Expected
Results and Benefits.’’ The content
requested in this section is similar to the
previous OPR without the added burden
of having the reporting organizations
provide the analysis that distinguish
between ‘‘results and benefits’’. Every
section of the document will be
rewritten to reflect this change.
OWP: ANA proposes to reformat the
OWP (content is same) by swapping the
Objective field with Problem Statement.
In other words, this section will require
respondents to begin with a concise
statement about the problem the project
is designed to address and will be
followed by more details about the
objectives of the project.
The two fields ‘‘Results Expected and
Benefits Expected’’ will be combined
into one field to read ‘‘Results and
benefits Expected’’. This will reduce
redundancy and help reduce the burden
on Grantees.
Respondents: Tribal Government,
Native non-profit organizations, Tribal
Colleges & Universities.
ANNUAL BURDEN ESTIMATES
Number of
respondents
Instrument
OWP ................................................................................................................
OPR .................................................................................................................
Estimated Total Annual Burden
Hours: 2,050.
Additional Information: Copies of the
proposed collection may be obtained by
writing to the Administration for
Children and Families, Office of
Planning, Research and Evaluation, 370
L’Enfant Promenade SW., Washington,
DC 20447, Attn: ACF Reports Clearance
Officer. All requests should be
identified by the title of the information
collection. Email address:
infocollection@acf.hhs.gov.
OMB Comment: OMB is required to
make a decision concerning the
collection of information between 30
and 60 days after publication of this
document in the Federal Register.
Therefore, a comment is best assured of
having its full effect if OMB receives it
within 30 days of publication. Written
comments and recommendation for the
proposed information collection should
be sent directly to the following: Office
of Management and Budget, Paperwork
Reduction Project, Fax: 202–395–7285,
Email: OIRA_SUBMISSION@
OMB.EOP.GOV, Attn: Desk Officer for
the Administration for Children and
families.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 2014–26785 Filed 11–12–14; 8:45 am]
BILLING CODE 4184–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
tkelley on DSK3SPTVN1PROD with NOTICES
Food and Drug Administration
[Docket No. FDA–2014–N–0001]
Science Board to the Food and Drug
Administration Advisory Committee
Meeting; Amendment of Notice
AGENCY:
Food and Drug Administration,
ACTION:
17:16 Nov 12, 2014
Jkt 235001
500
275
Notice.
The Food and Drug
Administration (FDA) is announcing an
amendment to the notice of meeting of
the Science Board to the Food and Drug
Administration. This meeting was
announced in the Federal Register of
October 8, 2014. The amendment is
being made to reflect changes in URL for
the Webcast. There are no other
changes.
SUMMARY:
Average
burden hours
per response
1
2
Total burden
hours
3
1
1,500
550
Dated: November 5, 2014.
Jill Hartzler Warner,
Associate Commissioner for Special Medical
Programs.
[FR Doc. 2014–26821 Filed 11–12–14; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2014–N–1732]
FOR FURTHER INFORMATION CONTACT:
Martha Monser, Office of the Chief
Scientist, Food and Drug
Administration, 10903 New Hampshire
Ave., Bldg. 1, Rm. 3309, Silver Spring,
MD 20993, 301–796–4627, or FDA
Advisory Committee Information Line,
1–800–741–8138 (301–443–0572 in the
Washington, DC area). Please call the
Information Line for up-to-date
information on this meeting.
In the
Federal Register of October 8, 2014 (79
FR 60856), FDA announced that a
meeting of the Science Board to the
Food and Drug Administration would
be held on November 19 and 20, 2014.
On page 60857, in the first column, the
URL information is changed to read as
follows:
The link for the Webcast on
November 19, 2014, is available at:
https://collaboration.fda.gov/
scienceboard111914/. The link for the
Webcast on November 20, 2014, is
available at: https://
collaboration.fda.gov/scienceboard
112014.
This notice is issued under the
Federal Advisory Committee Act (5
U.S.C. app. 2) and 21 CFR part 14,
relating to the advisory committees.
SUPPLEMENTARY INFORMATION:
HHS.
VerDate Sep<11>2014
Number of
responses per
respondent
PO 00000
Frm 00027
Fmt 4703
Sfmt 4703
Food Advisory Committee; Notice of
Meeting; Amendment of Notice
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing an
amendment to the notice of the meeting
of the Food Advisory Committee. This
meeting was announced in the Federal
Register of August 19, 2014. The
amendment is being made to add an
ADDRESSES section and to reflect a
change in the Agenda. There are no
other changes.
FOR FURTHER INFORMATION CONTACT:
Karen Strambler, Center for Food Safety
and Applied Nutrition, Food and Drug
Administration, 5100 Paint Branch
Pkwy., College Park, MD 20740, 240–
402–2589, FAX: 301–436–2637, email:
FoodAdvisoryCommittee@fda.hhs.gov,
or FDA Advisory Committee
Information Line, 1–800–741–8138
(301–443–0572 in the Washington, DC
area) and follow the prompts to the
desired Center or product area. Please
call the Information Line for up-to-date
information on this meeting.
SUPPLEMENTARY INFORMATION: In the
Federal Register of August 19, 2014 (79
FR 49091), FDA announced that a
meeting of the Food Advisory
SUMMARY:
E:\FR\FM\13NON1.SGM
13NON1
Federal Register / Vol. 79, No. 219 / Thursday, November 13, 2014 / Notices
Committee would be held on December
16–17, 2014. The ADDRESSES portion of
the document is to read as follows:
ADDRESSES: FDA is opening a docket for
public comment on this meeting. The
docket will open for public comment on
November 13, 2014. The docket will
close on January 15, 2014. Interested
persons may submit either electronic
comments regarding this meeting to
https://www.regulations.gov or written
comments to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, Rm.
1061, Rockville, MD 20852. It is only
necessary to send one set of comments.
Identify comments with the docket
number found in brackets in the
heading of this document. Received
comments may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday, and
will be posted to the docket at https://
www.regulations.gov. All comments
received will be posted without
changes, including any personal
information provided. Comments
received on or before December 1, 2014,
will be provided to the committee
before the meeting.
On page 49091, in the second column,
the Agenda portion of the document is
changed to read as follows:
Agenda: The committee will discuss
how risk assessments should account
for the susceptibility to the effects of a
particular chemical exposure because of
factors such as genetics, age, sex, and
health status and the circumstances
under which FDA would decide to
conduct a separate risk assessment for
these groups.
This notice is issued under the
Federal Advisory Committee Act (5
U.S.C. app. 2) and 21 CFR part 14,
relating to the advisory committees.
Dated: November 7, 2014.
Jill Hartzler Warner,
Associate Commissioner for Special Medical
Programs.
[FR Doc. 2014–26823 Filed 11–12–14; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
tkelley on DSK3SPTVN1PROD with NOTICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Proposed Collection: Public
Comment Request
Health Resources and Services
Administration, HHS.
AGENCY:
VerDate Sep<11>2014
17:16 Nov 12, 2014
Jkt 235001
ACTION:
Notice.
In compliance with the
requirement for opportunity for public
comment on proposed data collection
projects (Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995), the
Health Resources and Services
Administration (HRSA) announces
plans to submit an Information
Collection Request (ICR), described
below, to the Office of Management and
Budget (OMB). Prior to submitting the
ICR to OMB, HRSA seeks comments
from the public regarding the burden
estimate, below, or any other aspect of
the ICR.
DATES: Comments on this Information
Collection Request must be received no
later than January 12, 2015.
ADDRESSES: Submit your comments to
paperwork@hrsa.gov or mail the HRSA
Information Collection Clearance
Officer, Room 10C–03, Parklawn
Building, 5600 Fishers Lane, Rockville,
MD 20857.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and draft
instruments, email paperwork@hrsa.gov
or call the HRSA Information Collection
Clearance Officer at (301) 443–1984.
SUPPLEMENTARY INFORMATION: When
submitting comments or requesting
information, please include the
information request collection title for
reference.
Information Collection Request Title:
Evaluation and Initial Assessment of the
HRSA Teaching Health Centers
Graduate Medical Education Program.
OMB No.: 0906–xxxx—New.
Abstract: Section 5508 of the
Affordable Care Act of 2010 amended
section 340H of the Public Health
Service Act to establish the Teaching
Health Center Graduate Medical
Education (THCGME) program to
provide funding support for new and
the expansion of existing primary care
residency training programs in
community-based settings. The primary
goals of this program is to increase the
production of primary care providers
who are better prepared to practice in
community settings, particularly with
underserved populations, and improve
the geographic distribution of primary
care providers.
Statute requires the Secretary to
determine an appropriate THCGME
program payment for indirect medical
expenses (IME) as well as to update, as
deemed appropriate, the per resident
SUMMARY:
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
67439
amount used to determine the Program’s
payment for direct medical expenses
(DME). To inform these determinations
and to increase understanding of this
model of residency training, the George
Washington University (GW) is
conducting an evaluation of the costs
associated with training residents in the
Teaching Health Center (THC) model.
GW has developed a standardized
costing instrument to gather data from
all THCGME programs. The information
gathered in the standardized costing
instrument includes, but is not limited
to, resident and faculty full-time
equivalents, salaries and benefits,
residency administration costs,
educational costs, residency clinical
operations and administrative costs, and
patient visits and clinical revenue
generated by medical residents.
Need and Proposed Use of the
Information: HRSA is collecting costing
information related to both DME and
IME in an effort to establish a THC’s
total cost of running a residency
program, to assist the Secretary in
determining an appropriate update to
the per resident amount used to
calculate the payment for DME and an
appropriate IME payment. The
described data collection activities will
serve to inform these statutory
requirements for the Secretary in a
uniform and consistent manner.
Likely Respondents: THCGME
grantees.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install and utilize
technology and systems for the purpose
of collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this Information
Collection Request are summarized in
the table below.
The annual estimate of burden is as
follows:
E:\FR\FM\13NON1.SGM
13NON1
Agencies
[Federal Register Volume 79, Number 219 (Thursday, November 13, 2014)]
[Notices]
[Pages 67438-67439]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-26823]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2014-N-1732]
Food Advisory Committee; Notice of Meeting; Amendment of Notice
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing an
amendment to the notice of the meeting of the Food Advisory Committee.
This meeting was announced in the Federal Register of August 19, 2014.
The amendment is being made to add an ADDRESSES section and to reflect
a change in the Agenda. There are no other changes.
FOR FURTHER INFORMATION CONTACT: Karen Strambler, Center for Food
Safety and Applied Nutrition, Food and Drug Administration, 5100 Paint
Branch Pkwy., College Park, MD 20740, 240-402-2589, FAX: 301-436-2637,
email: FoodAdvisoryCommittee@fda.hhs.gov, or FDA Advisory Committee
Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC
area) and follow the prompts to the desired Center or product area.
Please call the Information Line for up-to-date information on this
meeting.
SUPPLEMENTARY INFORMATION: In the Federal Register of August 19, 2014
(79 FR 49091), FDA announced that a meeting of the Food Advisory
[[Page 67439]]
Committee would be held on December 16-17, 2014. The ADDRESSES portion
of the document is to read as follows:
ADDRESSES: FDA is opening a docket for public comment on this meeting.
The docket will open for public comment on November 13, 2014. The
docket will close on January 15, 2014. Interested persons may submit
either electronic comments regarding this meeting to https://www.regulations.gov or written comments to the Division of Dockets
Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852. It is only necessary to send one set of
comments. Identify comments with the docket number found in brackets in
the heading of this document. Received comments may be seen in the
Division of Dockets Management between 9 a.m. and 4 p.m., Monday
through Friday, and will be posted to the docket at https://www.regulations.gov. All comments received will be posted without
changes, including any personal information provided. Comments received
on or before December 1, 2014, will be provided to the committee before
the meeting.
On page 49091, in the second column, the Agenda portion of the
document is changed to read as follows:
Agenda: The committee will discuss how risk assessments should
account for the susceptibility to the effects of a particular chemical
exposure because of factors such as genetics, age, sex, and health
status and the circumstances under which FDA would decide to conduct a
separate risk assessment for these groups.
This notice is issued under the Federal Advisory Committee Act (5
U.S.C. app. 2) and 21 CFR part 14, relating to the advisory committees.
Dated: November 7, 2014.
Jill Hartzler Warner,
Associate Commissioner for Special Medical Programs.
[FR Doc. 2014-26823 Filed 11-12-14; 8:45 am]
BILLING CODE 4164-01-P